TP53 and cancer: In any event, it appears that the few prominent driver genes that are most frequently mutated in cancers; e.g., TP53 are not in themselves sufficient to promote the complex process of carcinogenesis; and recurrent but infrequently mutated “longtail” genes, many of which have not as yet been characterized, can promote oncogenesis.